At the 2023 American Association for Cancer Research Annual Meeting BI 765063, first-in-class SIRPα inhibitor on the SIRPα/CD47 myeloid pathway in advanced solid tumors. OSE-127, monoclonal immunomodulatory antibody targeting the CD127 receptor, the alpha chain of the interleukin-7 receptor (IL-7R) in Acute Lymphoblastic Leukemia. BiCKI®-IL-7, bifunctional therapy targeting PD1 and IL-7 to sustain exhausted T … [Read more…]

MARSEILLE, France–(BUSINESS WIRE)–#ANKET–Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or “AMF”) General Regulation, Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) releases its total number of shares outstanding as well as its … [Read more…]

Camera-based technology expected to help prevent automobile accidents TOKYO–(BUSINESS WIRE)–Mitsubishi Electric Corporation (TOKYO: 6503) announced today that it has developed a technology to detect serious physical conditions experienced by people driving automobiles, such as loss of consciousness, by estimating pulse rate, changes in blood pressure and other biometric data collected with a contactless Driver Monitoring … [Read more…]

BEIJING–(BUSINESS WIRE)–Data of InnoCare’s (HKEX: 09969; SSE: 688428) robust oncology pipelines were presented at the 2023 American Association for Cancer Research (AACR) Annual Meeting. Oral Presentation: ICP-490 is a highly potent and selective IKZF1/3 degrader with robust anti-tumor activities against multiple myeloma and non-Hodgkin’s lymphoma Abstract Number: 3427 In various multiple myeloma (MM) and non-Hodgkin’s … [Read more…]

TORONTO–(BUSINESS WIRE)–Greenbrook TMS Inc. (NASDAQ: GBNH) (“Greenbrook” or the “Company”), today announced its fourth quarter 2022 (“Q4 2022”) and year-end 2022 (“Fiscal 2022”) operational and financial results. All values in this news release are in United States dollars, unless otherwise stated. FISCAL 2022 OPERATIONAL AND FINANCIAL HIGHLIGHTS Fiscal 2022 revenue increased by 32% to $69.1 … [Read more…]

LONG BEACH, Calif.–(BUSINESS WIRE)–The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced the opening of the Hydrafacial Experience Center in Beijing. The Experience Center, Hydrafacial’s second location in China after Shanghai, will act as a flagship training facility for estheticians and a showroom to host influencers, editors and special events. Located … [Read more…]

Kansas Gastroenterology, LLC and Columbia University Irving Medical Center Enroll First Patients in Nation in Clinical Trial of Boomerang Medical’s Nerve Stimulation Device for Crohn’s Disease and Ulcerative Colitis MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–Boomerang Medical, a women-led bioelectronic medicine company, has announced the enrollment of the first patients in its U.S. clinical trial evaluating the use … [Read more…]

Global Public Health Organization Announces Update to C-Suite ANN ARBOR, Mich.–(BUSINESS WIRE)–NSF, a leading global public health and safety organization, today named Jose Luis Borrero its Chief Financial Officer. Borrero brings strong financial and operational leadership experience to his new role, where he will lead NSF’s global finance organization and oversee its numerous financial activities. … [Read more…]

New Drug Application (NDA) for sulbactam-durlobactam for the treatment of adults with hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by susceptible strains of Acinetobacter baumannii-calcoaceticus complex (Acinetobacter), is currently under Priority Review by the FDA with a PDUFA target action date of May 29, 2023 BURLINGAME, Calif.–(BUSINESS WIRE)–Innoviva, Inc. (Nasdaq: INVA) (Innoviva), a diversified … [Read more…]

PIOMBINO DESE, Italy–(BUSINESS WIRE)–Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the first quarter of 2023 on Thursday, May 4, 2023, at 6:30 a.m. (ET). Conference call and webcast: … [Read more…]